Emerging Trends in Cancer Research

Cancer Overview and Indian Context

• Cancer Statistics in India (2026): Estimation of 1.87 million new cases, equating to 1 in 9 Indians at lifetime risk of developing cancer.
• Economic Impact: Direct and indirect medical costs estimated at ₹3,400 crores, excluding income loss, debt, and caregiver burden.

Space Oncology

• Emerging Field: Investigates impacts of microgravity and cosmic radiation on cancer progression and treatment.
• Research Benefits: Space environments assist in tumor modeling, drug discovery, and have led to technological advances like 3D cell culture systems.

Biological Responses

• Microgravity Effects: Changes in cancer cell behavior; alterations include cytoskeletal reorganization and modified extracellular interactions which impact therapy responses and metastatic behavior.
• Drug Development Conduit: Microgravity aids in creating more stable drug formulations, reducing reliance on animal testing.

International Research and Findings

• International Space Station (ISS): Studies have examined various cancers (breast, lung, thyroid, etc.) under microgravity, revealing unique cellular behaviors.
• Frontline Discoveries: Effects include changes in cell adhesion, gene expression, and drug response characteristics of cancer cells.

Regulatory Developments

• FDA Approvals:
  • Pembrolizumab: Immunotherapy drug for cancer, sourced from ISS research; targeting the ADAR1 gene with uniform protein crystals.
  • Rebecsinib: First space-tested cancer drug to enter clinical trials, gaining FDA Investigational New Drug status.

UK Advancements

• Dual-Regulation Initiatives: U.K. regulators streamlined processes for space pharmacology, encouraging commercial investments in space-based therapies.

Indian Space Research Organisation (ISRO)

• Position: 3rd largest global space-tech power with a focus on reducing launch costs for broader accessibility to space oncology.
• Market Potential: Microgravity pharmaceutical manufacturing projected to grow from $1.5 billion in 2025 to $9.8 billion by 2034.

Future Implications

• Commercial Space Production: Shift from research to commercial viability in space pharmaceutical manufacturing with ventures being established in India.
• Holistic Approach: Opportunities for the development of self-injectable cancer therapies emerging from space-based research initiatives.

Significant Research Outputs

• Publications: Over 700 peer-reviewed papers, 40 chapters, and 12 monographs on space oncology, indicating a growing body of knowledge and ongoing research.

Conclusion

• Space oncology represents a viable path for innovative cancer therapies and research, reflecting a convergence of healthcare and space exploration aimed at addressing a global health challenge.